Litigation Details for Delcor Asset Corporation v. Glenmark Pharmaceuticals Limited (D. Del. 2017)
✉ Email this page to a colleague
Delcor Asset Corporation v. Glenmark Pharmaceuticals Limited (D. Del. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-11-15 |
| Court | District Court, D. Delaware | Date Terminated | 2019-03-05 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | Defendant | Referred To | |
| Patents | 7,141,237; 7,374,747 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Delcor Asset Corporation v. Glenmark Pharmaceuticals Limited
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Delcor Asset Corporation v. Glenmark Pharmaceuticals Limited (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2017-11-14 | 1 | United States Patent Nos. 7,141,237 (“the ’237 patent”) and 7,374,747 (“the ’747 patent”) arising under… INFRINGEMENT OF U.S. PATENT NO. 7,141,237 40. Delcor repeats and realleges…DECLARATORY JUDGMENT OF INFRINGEMENT OF U.S. PATENT NO. 7,141,237 45. Delcor repeats and realleges… THE PATENTS-IN-SUIT 14. The ’237 patent, titled “Pharmaceutical Foam…forth in greater detail in the ’237 patent, the claims of the ’237 patent, incorporated by reference herein | External link to document | |
| 2019-03-05 | 130 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,141,237; 7,374,747. (Attachments…2017 5 March 2019 1:17-cv-01653 835 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document |
| 2017-11-14 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,141,237; 7,374,747. (nmfn) …2017 5 March 2019 1:17-cv-01653 835 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document | |
| 2018-04-25 | 57 | Initial Invalidity Contentions Regarding U.S. Patent Nos. 7,141,237 and 7,374,747 filed by Glenmark Pharmaceuticals…2017 5 March 2019 1:17-cv-01653 835 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document | |
| 2018-10-31 | 93 | multiple terms in U.S . Patent Nos. 7,141 ,237 ("the '237 patent") and 7,374,747 ("…construction for multiple terms in U.S. Patent Nos. 7,141,237 and 7,374,747. Signed by Judge Richard G…Ill. PATENTS AT ISSUE The '747 patent is a continuation of the '237 patent and the…237 and ' 747 patents. (D.I. 1 ,r,r 19- 20). Stiefel owns the asserted patents but was joined as …quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
